XML 84 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Geographic and Product Data
 12 Months Ended
Jan. 02, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 16 — Geographic and Product Data
 
The Company markets and sells its products in approximately 60 countries and has manufacturing in the United States. Other than the United States, Japan, Korea, China, Spain and France, the Company does not conduct business in any country in which its sales in that country exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s sales to unaffiliated customers is set forth below (in thousands):
 
Net sales to unaffiliated customers
 
2014
 
2013
 
2012
 
United States
 
$
11,117
 
$
12,851
 
$
12,427
 
Japan
 
 
19,107
 
 
17,666
 
 
16,692
 
China
 
 
9,370
 
 
8,618
 
 
8,406
 
Korea
 
 
6,563
 
 
7,743
 
 
6,713
 
Spain
 
 
5,562
 
 
4,867
 
 
3,026
 
France
 
 
3,696
 
 
2,546
 
 
1,612
 
Others*
 
 
19,572
 
 
17,924
 
 
14,907
 
Total
 
$
74,987
 
$
72,215
 
$
63,783
 
 
*No other location individually exceeds 5% of total sales.
 
100% of the Company’s sales are generated from the ophthalmic surgical product segment and, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery. The composition of the Company’s net sales by product line is as follows (in thousands):
 
Net sales by product line
 
2014
 
2013
 
2012
 
ICLs
 
$
44,047
 
$
44,128
 
$
35,080
 
IOLs
 
 
24,336
 
 
24,153
 
 
25,971
 
Other surgical products
 
 
6,604
 
 
3,934
 
 
2,732
 
Total
 
$
74,987
 
$
72,215
 
$
63,783
 
 
The composition of the Company’s long-lived assets, consisting of property and equipment, between those in the United States, Switzerland, and Japan is set forth below (in thousands):
 
Long-lived assets
 
2014
 
2013
 
U.S.
 
$
9,127
 
$
6,096
 
Switzerland
 
 
596
 
 
849
 
Japan
 
 
343
 
 
460
 
Total
 
$
10,066
 
$
7,405
 
 
The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.